Korbel Gregory Alan

SVP, Chief Business Officer at APRE

Sold, on record
$545k
Dollars the filings state
Form 4 sales
4
Latest Dec 1, 2021
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • APREAprea Therapeutics, Inc.SVP, Chief Business Officer

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale APREUnusual
    Sep 20 2021

    Sold 32,960 shares at $4.97 ($164k)

    Korbel Gregory Alan, SVP, Chief Business Officer

    Sold 65.8% of holdings ($249k position)17,167 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale APREUnusual
    Oct 1 +11 days

    Sold 27,500 shares at $4.89 ($134k)

    Korbel Gregory Alan, SVP, Chief Business Officer

    Sold 61.6% of holdings ($218k position)17,167 shares leftFiling

  3. 3 Form 4 sale APREUnusual
    Nov 1 +31 days

    Sold 27,500 shares at $5.00 ($138k)

    Korbel Gregory Alan, SVP, Chief Business Officer

    Sold 61.6% of holdings ($223k position)17,167 shares leftFiling

  4. 4 Form 4 sale APREUnusual
    Dec 1 +30 days

    Sold 27,500 shares at $3.96 ($109k)

    Korbel Gregory Alan, SVP, Chief Business Officer

    Sold 61.6% of holdings ($177k position)17,167 shares left1x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (4)

Form 144 notices and Form 4 sales by Korbel Gregory Alan
Source
Dec 1, 2021APRESVP, Chief Business OfficerForm 4 sale27,500$109k61.6%UnusualSEC
Nov 1, 2021APRESVP, Chief Business OfficerForm 4 sale27,500$138k61.6%UnusualSEC
Oct 1, 2021APRESVP, Chief Business OfficerForm 4 sale27,500$134k61.6%UnusualSEC
Sep 20, 2021APRESVP, Chief Business OfficerForm 4 sale32,960$164k65.8%UnusualSEC